תפריט כתבה
Programmable CRISPR platform can reduce stem cell differentiation from months to weeks
Phys
22:00
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, which lays the groundwork for programmable control of gene activity in human stem cells and offers an alternative to the slow, variable manual processes researchers use today.
